BASF PHARMA (CALLANISH) LIMITED

Active Stockport

Manufacture of oils and fats

74 employees website.com
Manufacture of oils and fats
B

BASF PHARMA (CALLANISH) LIMITED

Manufacture of oils and fats

Founded 13 Jul 2005 Active Stockport, United Kingdom 74 employees website.com
Manufacture of oils and fats

Previous Company Names

EQUATEQ LIMITED 13 Jul 2005 — 15 May 2012
Accounts Submitted 9 Jul 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 8 Jul 2025 Next due 22 Jul 2026 2 months remaining
Net assets £-53M £9M 2024 year on year
Total assets £26M £4M 2024 year on year
Total Liabilities £79M £5M 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

4th And 5th Floors 2 Stockport Exchange Railway Road Stockport SK1 3GG United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BASF PHARMA (CALLANISH) LIMITED (05507387), an active company based in Stockport, United Kingdom. Incorporated 13 Jul 2005. Manufacture of oils and fats. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Net Assets

-£52.83M

Decreased by £8.83M (-20%)

Total Liabilities

£78.74M

Increased by £4.89M (+7%)

Turnover

£11.51M

Decreased by £7.37M (-39%)

Employees

74

Decreased by 2 (-3%)

Debt Ratio

304%

Increased by 57 (+23%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Timothy HolsteinDirectorBritishEngland401 Sept 2023Active

Shareholders

Shareholders (1)

Basf Pharma Belgium
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Basf Se

Germany

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

BASF PHARMA (CALLANISH) LIMITED Current Company

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Apr 2026OfficersTermination of Darren Budd as director on 17 Apr 2026
8 Jan 2026OfficersChange Person Secretary Company With Change Date
9 Jul 2025AccountsAnnual accounts made up to 31 Dec 2024
8 Jul 2025Confirmation StatementConfirmation statement made on 8 Jul 2025 with no updates
11 Jun 2025OfficersAppointment of Dr Eva Maria Schweitzer as director on 1 Jun 2025
22 Apr 2026 Officers

Termination of Darren Budd as director on 17 Apr 2026

8 Jan 2026 Officers

Change Person Secretary Company With Change Date

9 Jul 2025 Accounts

Annual accounts made up to 31 Dec 2024

8 Jul 2025 Confirmation Statement

Confirmation statement made on 8 Jul 2025 with no updates

11 Jun 2025 Officers

Appointment of Dr Eva Maria Schweitzer as director on 1 Jun 2025

Recent Activity

Latest Activity

Termination of Darren Budd as director on 17 Apr 2026

1 weeks ago on 22 Apr 2026

Change Person Secretary Company With Change Date

3 months ago on 8 Jan 2026

Annual accounts made up to 31 Dec 2024

9 months ago on 9 Jul 2025

Confirmation statement made on 8 Jul 2025 with no updates

10 months ago on 8 Jul 2025

Appointment of Dr Eva Maria Schweitzer as director on 1 Jun 2025

10 months ago on 11 Jun 2025